Latest Asx Quarterly Reports News

ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.

One Click Group delivered a remarkable 1000% increase in new users and a 64% reduction in acquisition costs in Q1 2026, setting the stage for strong revenue growth ahead of tax season.

eMetals Limited has solidified its foothold in high-grade tungsten with a binding acquisition in Utah, while its Ugandan gold projects reveal promising soil anomalies amid ongoing exploration.

Alcidion Group delivered positive cashflow and strong new sales in Q3 FY26, with contract expansions in the UK and Australia. The company remains on track for a significant Electronic Patient Record contract signing in May.

TG Metals has expanded its Van Uden gold resource to 270,800 ounces with a 120% increase in indicated ounces, discovered new mineralisation 550m south, and filed a lithium processing patent at Lake Johnston.

Stonehorse Energy Limited reported steady operational and financial performance for Q1 2026, driven by successful drilling in Canada and solid oil and gas production across its North American portfolio.

Advanced Braking Technology Ltd (ASX: ABV) reported a 28% jump in product sales revenue to $6 million for Q3 FY26, driven by strong aftermarket sales and international market traction. The company also advanced certification of its autonomous BRAKEiQ system, targeting FY27 adoption.

Astral Resources has reported strong drilling results across its Western Australian gold projects, progressing the Mandilla Definitive Feasibility Study (DFS) and securing $1.76 million in a recent placement tranche. The company maintains a healthy cash position of $73 million as it targets first gold production in early 2028.

Admiralty Resources reported a $3.1 million cash outflow for the December quarter, with less than one quarter of funding available. Despite this, the company expects to maintain operations supported by iron ore sales and a significant prepayment.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Simble Solutions reports new multi-year contracts in the UK and Australia, boosting revenue prospects, but faces a cash runway of less than one quarter and is exploring funding options.

ARC Funds Limited reports a solid September quarter with a $634,000 equity placement, positive cash flow, and the successful integration of The Term Deposit Shop, positioning itself for further expansion.